Luca Maurillo

20PUBLICATIONS
131CO-AUTHORS
NanomedicineMedical infection agents (incl. prions)Gene and molecular therapyMedical mycologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Jan 28, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients.

Elisa Buzzatti, Cristina Mauro, Cristiano Tesei

|Jan 13, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort.

Calogero Vetro, Irene Azzali, Elisabetta Petracci

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|Sep 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Fabio Guolo, Luana Fianchi, Maria Paola Martelli

|Jun 26, 2025
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy.

Elisa Buzzatti, Giovangiacinto Paterno, Raffaele Palmieri

Pageof 4

Frequent Collaborators

13 joint publications

Adriano Venditti

12 joint publications

Francesco Buccisano

11 joint publications

Raffaele Palmieri

6 joint publications

Giovangiacinto Paterno